Galakatos says 'the most important current breakthrough in science is our increasing ability to practise precision medicine based on our understanding of the human genome.'
15.08.2022 - All FREEDOM-1 patients who received FCR001 at least three months prior to the data cutoff date of June 15, 2022 had achieved and maintained
Greece is able to attract investments in
demanding cutting-edge technologies such as biotechnology, Greek Prime
Minister Kyriakos Mitsotakis said on Thursday.
Talaris Therapeutics (TALS) Appoints Karen Smith to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
RIYADH: American leading alternative investment management company, Blackstone, has raised as much as $1.6 billion for new drugs and therapies development. The amount will be used to invest in firms with products that have green light for commercial use, as well as royalties that are linked to drug sales, according to Nicholas Galakatos, head of Blackstone’s life-sciences arm.